11 research outputs found

    Electrosynthèse d'esters aryl- et benzylboroniques (aspects mécanistiques)

    No full text
    L utilisation du procédé à anode soluble pour l élaboration d halogénures d aryle polyhalogénés ou fonctionnalisés par des groupements nitrile ou ester carboxylique a été développée en présence de pinacolborane et a permis d obtenir les esters arylboroniques correspondants avec de bonnes sélectivités. La mise au point d une nouvelle voie d électrosynthèse d acides et d esters benzylboroniques basée sur l utilisation de méthodes électrochiliques a permis la boration de substrats benzyliques par divers agents boratants (comme les trialkyl borates ou encore les dialkoxyboranes). Une approche mécanistique de la réaction d électrosynthèse a permis de proposer une réduction des composés organoborés et l évolution vers un produit de couplage par transfert électroniques. Les études mécanistiques ont permis de développer une nouvelle synthèse d acides et d esters aryl- et benzylboroniques par voie conventionnelle mettant en jeu me dérivé halogéné benzylique, le pinacolborane et la triéthylamine dans un système catalytique en magnésium (0). Nous proposons un cycle catalytique pour cette réaction.Functionalized aryl halides using sacrificial process allows the access to the corresponding arylboronic esters with good selectivity. A novel strategy for the one-step synthesis of benzylboronic acids and esters by using and electrochemical methodology is presented. The electrochemical functionalization of benzyl halides by several borating agents has been developed.Mechanistic studies on the elaboration in the presence of trialkyl borates reveal the possibility of the electroreduction of the borating agent followed by an electronic transfer. The studies of the electrolysis of benzyl halides in the presence of pinacolborane consider the electroreduction of benzyl halides to generate in situ organometallic species. These mechanistic considerations led us to develop a new preparation of aryl- and benzylboronic esters involving the halogenated derivative, pinacolborane and triethylamine in a new catalytic system using 10 mol% of magnesium(0). A catalytic cycle is proposed to understand the mechanism.NICE-BU Sciences (060882101) / SudocSudocFranceF

    An opportunity for Mg-catalyzed Grignard-type reactions: direct coupling of benzylic halides with pinacolborane with 10 mol % of magnesium.

    No full text
    International audienceMg in catalytic amounts as the only metal permits the reductive coupling between benzyl halides and pinacolborane. HBpin acts both as an electrophile and as a reducing agent to regenerate an organomagnesium species in situ. An hydride oxidation mechanism is proposed on the basis of DFT calculations

    ChemInform Abstract: An Opportunity for Mg-Catalyzed Grignard-Type Reactions: Direct Coupling of Benzylic Halides with Pinacolborane with 10 mol% of Magnesium.

    No full text
    International audienceMg in catalytic amounts as the only metal permits the reductive coupling between benzyl halides and pinacolborane. HBpin acts both as an electrophile and as a reducing agent to regenerate an organomagnesium species in situ. An hydride oxidation mechanism is proposed on the basis of DFT calculations

    Alirocumab in patients with polyvascular disease and recent acute coronary syndrome ODYSSEY OUTCOMES trial

    No full text

    Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

    No full text

    Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial

    No full text
    10.1161/CIRCULATIONAHA.118.038840CIRCULATION1402103-11

    Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial

    No full text

    Alirocumab reduces total hospitalizations and increases days alive and out of hospital in the ODYSSEY OUTCOMES trial

    No full text

    Risk categorization using New American College of Cardiology/American Heart Association guidelines for cholesterol management and its relation to alirocumab treatment following acute coronary syndromes

    No full text

    Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial

    No full text
    corecore